Ocular Therapeutix (OCUL) EPS (Weighted Average and Diluted): 2018-2025
Historic EPS (Weighted Average and Diluted) for Ocular Therapeutix (OCUL) over the last 7 years, with Sep 2025 value amounting to -$0.38.
- Ocular Therapeutix's EPS (Weighted Average and Diluted) fell 72.73% to -$0.38 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.43, marking a year-over-year decrease of 17.21%. This contributed to the annual value of -$1.22 for FY2024, which is 19.61% down from last year.
- According to the latest figures from Q3 2025, Ocular Therapeutix's EPS (Weighted Average and Diluted) is -$0.38, which was up 2.56% from -$0.39 recorded in Q2 2025.
- Ocular Therapeutix's EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.22 during Q1 2022, with a 5-year trough of -$0.49 in Q1 2024.
- In the last 3 years, Ocular Therapeutix's EPS (Weighted Average and Diluted) had a median value of -$0.28 in 2024 and averaged -$0.32.
- In the last 5 years, Ocular Therapeutix's EPS (Weighted Average and Diluted) surged by 82.84% in 2021 and then plummeted by 77.27% in 2023.
- Ocular Therapeutix's EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.23 in 2021, then fell by 4.35% to -$0.24 in 2022, then fell by 4.17% to -$0.25 in 2023, then decreased by 12.00% to -$0.28 in 2024, then plummeted by 72.73% to -$0.38 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.38 for Q3 2025, versus -$0.39 for Q2 2025 and -$0.38 for Q1 2025.